Predictive Healthcare, Inc

Predictive Healthcare, Inc. develops MyHealthPal™, an FDA-listed Class I medical device platform for remote postoperative surgical site infection (SSI) monitoring. The platform uses artificial intelligence and standard consumer smart devices (smartphones) to enable patients to submit wound photos and clinical inputs that feed into an algorithm assessing SSI risk in real time. Clinicians receive predictive risk alerts to guide postoperative decision-making and early intervention. The system integrates with existing electronic medical record (EMR) systems and supports asynchronous postoperative visits, reducing unnecessary in-person wound checks while maintaining vigilant monitoring for patients with geographic or social barriers to care access. MyHealthPal addresses a significant clinical need: approximately 5 in 100 surgeries result in SSI, costing US hospitals $10 billion annually. The company is FDA-registered and operates under a Class I medical device designation. The platform is currently available for sale in the United States only and is positioned for perioperative programs across surgical specialties, with demonstrated interest in orthopedic, spinal, pediatric, and general surgery applications.